UBS Reiterates Buy on AbbVie (ABBV) Following Conference Call

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. GLOB
2. AMAT
3. RDDT
4. ELUT
5. YSS
6. SMSI
7. SNDK
8. ADYEN:NA
9. XYL
10. ADYYF

Go back to UBS Reiterates Buy on AbbVie (ABBV) Following Conference Call

AbbVie Reports Third-Quarter 2015 Financial Results

October 30, 2015 6:55 AM EDT

NORTH CHICAGO, Ill., Oct. 30, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced financial results for the third quarter ended September 30, 2015.

"We are pleased with our outperformance in the third quarter and our progress year-to-date. We've driven strong commercial, operational and R&D execution, resulting in industry-leading top- and bottom-line performance," said Richard A. Gonzalez, chairman and chief executive officer, AbbVie. "We are well-positioned to deliver robust EPS growth in 2015 and beyond, and we continue to make significant progress advancing our pipeline and other strategic actions that will help AbbVie achieve top-tier growth over the... More

AbbVie Outlines Long-Term Strategic and Financial Objectives; Company Positioned for Strong Performance

October 30, 2015 6:54 AM EDT

NORTH CHICAGO, Ill., Oct. 30, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) today outlined the company's long-term strategic and financial objectives, including expectations for growth and other financial metrics over its long-range plan, through 2020.

"AbbVie is well-positioned to deliver strong top- and bottom-line performance through 2020 and beyond," said Richard A. Gonzalez, chairman and chief executive officer, AbbVie. "We have built a strong foundation, establishing growth platforms in some of the largest and most attractive market segments. And, we have a robust and compelling pipeline which will contribute significantly to our performance over our... More